BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8266793)

  • 1. Mucosal exudation of fibrinogen in coronavirus-induced common colds.
    Akerlund A; Greiff L; Andersson M; Bende M; Alkner U; Persson CG
    Acta Otolaryngol; 1993 Sep; 113(5):642-8. PubMed ID: 8266793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular exudative hyperresponsiveness in human coronavirus-induced common cold.
    Greiff L; Andersson M; Akerlund A; Wollmer P; Svensson C; Alkner U; Persson CG
    Thorax; 1994 Feb; 49(2):121-7. PubMed ID: 8128400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal cytokines in common cold and allergic rhinitis.
    Linden M; Greiff L; Andersson M; Svensson C; Akerlund A; Bende M; Andersson E; Persson CG
    Clin Exp Allergy; 1995 Feb; 25(2):166-72. PubMed ID: 7750009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical nitroprusside may reduce histamine-induced plasma exudation in human nasal airways.
    Greiff L; Andersson M; Svensson C; Nilsson M; Erjefält I; Erjefält JS; Persson CG
    Allergy; 1995 Jul; 50(7):593-7. PubMed ID: 8588693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal mucosal endorgan hyperresponsiveness.
    Svensson C; Andersson M; Greiff L; Persson CG
    Am J Rhinol; 1998; 12(1):37-43. PubMed ID: 9513658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of two weeks of topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways.
    Greiff L; Andersson M; Svensson C; Akerlund A; Alkner U; Persson CG
    Eur Respir J; 1997 Apr; 10(4):841-5. PubMed ID: 9150322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal neutrophil activity and mucinous secretory responsiveness in COPD.
    Nihlén U; Andersson M; Löfdahl CG; Persson CG; Montnémery P; Greiff L
    Clin Physiol Funct Imaging; 2003 May; 23(3):138-42. PubMed ID: 12752555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine-induced airway mucosal exudation of bulk plasma and plasma-derived mediators is not inhibited by intravenous bronchodilators.
    Svensson C; Alkner U; Pipkorn U; Persson CG
    Eur J Clin Pharmacol; 1994; 46(1):59-65. PubMed ID: 8005188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of experimental changes in nasal airway pressure on mucosal output of plasma.
    Berg S; Wollmer P; Andersson M; Persson CG; Greiff L
    Clin Physiol Funct Imaging; 2003 May; 23(3):155-8. PubMed ID: 12752558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "nasal pool"-device for challenge and lavage of the nasal mucosa in children: histamine-induced plasma exudation responses.
    Greiff L; Meyer P; Svensson C; Persson CG; Andersson M
    Pediatr Allergy Immunol; 1997 Aug; 8(3):137-42. PubMed ID: 9532254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-linked fibrin in the nasal fluid of patients with the common cold.
    Winther B; Gwaltney JM; Humphries JE; Hendley JO
    Clin Infect Dis; 2002 Mar; 34(5):708-10. PubMed ID: 11823958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory threshold and nasal mucosal changes in experimentally induced common cold.
    Akerlund A; Bende M; Murphy C
    Acta Otolaryngol; 1995 Jan; 115(1):88-92. PubMed ID: 7762392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Day-night differences in mucosal plasma proteins in common cold.
    Greiff L; Akerlund A; Andersson M; Svensson C; Alkner U; Persson CG
    Acta Otolaryngol; 1996 Jan; 116(1):85-90. PubMed ID: 8820357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenge-induced plasma exudation and mucinous secretion in human airways.
    Greiff L; Andersson M; Coman WB; Lindberg H; Marko-Varga G; Wallwork B; Persson CG
    Clin Physiol Funct Imaging; 2005 Jul; 25(4):241-5. PubMed ID: 15972027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways.
    Svensson C; Pipkorn U; Alkner U; Baumgarten CR; Persson CG
    Clin Exp Allergy; 1992 Mar; 22(3):411-6. PubMed ID: 1586878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis.
    Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X
    Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset of action of a topical antihistamine as assessed by histamine challenge-induced plasma exudation responses.
    Korsgren M; Andersson M; Larsson L; Aldén-Raboisson M; Greiff L
    Ann Allergy Asthma Immunol; 2006 Feb; 96(2):345-8. PubMed ID: 16498858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversibility and reproducibility of histamine induced plasma leakage in nasal airways.
    Svensson C; Baumgarten CR; Pipkorn U; Alkner U; Persson CG
    Thorax; 1989 Jan; 44(1):13-8. PubMed ID: 2648641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold.
    Avila PC; Abisheganaden JA; Wong H; Liu J; Yagi S; Schnurr D; Kishiyama JL; Boushey HA
    J Allergy Clin Immunol; 2000 May; 105(5):923-32. PubMed ID: 10808173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in human nasal mucosa during experimental coronavirus common colds.
    Bende M; Barrow I; Heptonstall J; Higgins PG; Al-Nakib W; Tyrrell DA; Akerlund A
    Acta Otolaryngol; 1989; 107(3-4):262-9. PubMed ID: 2538995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.